S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
S&P 500   3,768.25
DOW   30,814.26
QQQ   311.86
pixel
Log in
NYSE:SYK

Stryker Stock Forecast, Price & News

$241.99
-0.14 (-0.06 %)
(As of 01/15/2021 12:00 AM ET)
Add
Compare
Today's Range
$238.75
Now: $241.99
$243.66
50-Day Range
$230.95
MA: $238.18
$245.04
52-Week Range
$124.54
Now: $241.99
$247.44
Volume1.18 million shs
Average Volume1.12 million shs
Market Capitalization$90.94 billion
P/E Ratio57.48
Dividend Yield1.04%
Beta0.78
Stryker Corporation operates as a medical technology company. The company operates through three segments: Orthopaedics, MedSurg, and Neurotechnology and Spine. The Orthopaedics segment provides implants for use in hip and knee joint replacements, and trauma and extremities surgeries. The MedSurg segment offers surgical equipment and surgical navigation systems, endoscopic and communications systems, patient handling, emergency medical equipment and intensive care disposable products, reprocessed and remanufactured medical devices, and other medical devices that are used in various medical specialties. The Neurotechnology and Spine segment provides neurotechnology products, which include products used for minimally invasive endovascular techniques; products for brain and open skull based surgical procedures; orthobiologic and biosurgery products, such as synthetic bone grafts and vertebral augmentation products; and minimally invasive products for the treatment of acute ischemic and hemorrhagic stroke. This segment also provides spinal implant products comprising cervical, thoracolumbar, and interbody systems that are used in spinal injury, deformity, and degenerative therapies. The company sells its products to doctors, hospitals, and other healthcare facilities through company-owned subsidiaries and branches, as well as third-party dealers and distributors in approximately 75 countries. Stryker Corporation was founded in 1941 and is headquartered in Kalamazoo, Michigan.
Stryker logo

MarketRank

Overall MarketRank

2.02 out of 5 stars

Medical Sector

39th out of 1,480 stocks

Surgical & Medical Instruments Industry

8th out of 135 stocks

Analyst Opinion: 2.3Community Rank: 2.6Dividend Strength: 1.7Insider Behavior: 1.7Valuation: 1.9 5 -4 -3 -2 -1 -

Industry, Sector and Symbol

Industry Surgical & medical instruments
Sub-IndustryHealth Care Equipment
SectorMedical
CUSIP86366710
Phone269-389-2600
Employees40,000

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$14.88 billion
Cash Flow$11.47 per share
Book Value$34.23 per share

Profitability

Net Income$2.08 billion

Miscellaneous

Market Cap$90.94 billion
Next Earnings Date1/27/2021 (Confirmed)
OptionableOptionable
$241.99
-0.14 (-0.06 %)
(As of 01/15/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive SYK News and Ratings via Email

Sign-up to receive the latest news and ratings for SYK and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Stryker (NYSE:SYK) Frequently Asked Questions

How has Stryker's stock price been impacted by COVID-19 (Coronavirus)?

Stryker's stock was trading at $175.62 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, SYK shares have increased by 37.8% and is now trading at $241.99.
View which stocks have been most impacted by COVID-19
.

Is Stryker a buy right now?

24 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Stryker in the last twelve months. There are currently 2 sell ratings, 7 hold ratings, 14 buy ratings and 1 strong buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" Stryker stock.
View analyst ratings for Stryker
or view MarketBeat's top 5 stock picks.

What stocks does MarketBeat like better than Stryker?

Wall Street analysts have given Stryker a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Stryker wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

When is Stryker's next earnings date?

Stryker is scheduled to release its next quarterly earnings announcement on Wednesday, January 27th 2021.
View our earnings forecast for Stryker
.

How can I listen to Stryker's earnings call?

Stryker will be holding an earnings conference call on Wednesday, January 27th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Stryker's earnings last quarter?

Stryker Co. (NYSE:SYK) issued its quarterly earnings data on Thursday, October, 29th. The medical technology company reported $2.14 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $1.40 by $0.74. The medical technology company had revenue of $3.74 billion for the quarter, compared to analyst estimates of $3.41 billion. Stryker had a return on equity of 20.53% and a net margin of 11.38%. The business's revenue was up 4.2% on a year-over-year basis. During the same quarter last year, the business earned $1.91 EPS.
View Stryker's earnings history
.

How often does Stryker pay dividends? What is the dividend yield for Stryker?

Stryker declared a quarterly dividend on Wednesday, December 2nd. Stockholders of record on Thursday, December 31st will be paid a dividend of $0.63 per share on Friday, January 29th. This represents a $2.52 dividend on an annualized basis and a dividend yield of 1.04%. The ex-dividend date of this dividend is Wednesday, December 30th. This is a positive change from Stryker's previous quarterly dividend of $0.58.
View Stryker's dividend history
.

Is Stryker a good dividend stock?

Stryker pays an annual dividend of $2.52 per share and currently has a dividend yield of 1.04%. Stryker does not yet have a strock track record of dividend growth. The dividend payout ratio of Stryker is 30.51%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, Stryker will have a dividend payout ratio of 28.41% next year. This indicates that Stryker will be able to sustain or increase its dividend.
View Stryker's dividend history.

What price target have analysts set for SYK?

24 equities research analysts have issued twelve-month target prices for Stryker's shares. Their forecasts range from $150.00 to $278.00. On average, they expect Stryker's share price to reach $227.48 in the next year. This suggests that the stock has a possible downside of 6.0%.
View analysts' price targets for Stryker
or view Wall Street analyst' top-rated stocks.

Who are some of Stryker's key competitors?

What other stocks do shareholders of Stryker own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Stryker investors own include Johnson & Johnson (JNJ), The Walt Disney (DIS), The Home Depot (HD), Medtronic (MDT), Visa (V), AbbVie (ABBV), Cisco Systems (CSCO), Intel (INTC), QUALCOMM (QCOM) and NVIDIA (NVDA).

Who are Stryker's key executives?

Stryker's management team includes the following people:
  • Mr. Kevin A. Lobo, Chairman & CEO (Age 56, Pay $4.37M)
  • Mr. Timothy J. Scannell, Pres & COO (Age 56, Pay $2.06M)
  • Mr. Glenn S. Boehnlein, VP & CFO (Age 59, Pay $1.65M)
  • Mr. Robert S. Fletcher, VP & Chief Legal Officer (Age 50, Pay $831.18k)
  • Mr. Viju S. Menon, Group Pres of Global Quality & Operations (Age 53, Pay $1.26M)
  • Mr. Robert C. Cohen, CTO and VP of Global R&D - Joint Replacement
  • Mr. Alan Douville, VP, Chief Information Officer & Chief Information Security Officer
  • Mr. Preston Wells, VP of Investor Relations
  • Ms. Bronwen R. Taylor, VP of Compliance & Risk Management
  • Ms. Yin C. Becker, VP of Communications, Public Affairs & Corp. Marketing (Age 57)

What is Stryker's stock symbol?

Stryker trades on the New York Stock Exchange (NYSE) under the ticker symbol "SYK."

Who are Stryker's major shareholders?

Stryker's stock is owned by many different retail and institutional investors. Top institutional investors include Loring Wolcott & Coolidge Fiduciary Advisors LLP MA (0.36%), Boston Trust Walden Corp (0.11%), Ardevora Asset Management LLP (0.07%), Chesley Taft & Associates LLC (0.04%), Tandem Investment Advisors Inc. (0.04%) and Huntington National Bank (0.04%). Company insiders that own Stryker stock include Allan C Golston, Bijoy Sagar, Glenn S Boehnlein, Katherine Ann Owen, Kevin Lobo, Louise Francesconi, M Kathryn Fink, Michael Damon Hutchinson, Roch Doliveux, Srikant M Datar, Timothy J Scannell and Yin C Becker.
View institutional ownership trends for Stryker
.

Which institutional investors are selling Stryker stock?

SYK stock was sold by a variety of institutional investors in the last quarter, including Crossmark Global Holdings Inc., Ardevora Asset Management LLP, State of Alaska Department of Revenue, Huntington National Bank, Fulton Breakefield Broenniman LLC, CX Institutional, Chesley Taft & Associates LLC, and LVM Capital Management Ltd. MI. Company insiders that have sold Stryker company stock in the last year include Allan C Golston, Glenn S Boehnlein, Katherine Ann Owen, Kevin Lobo, Srikant M Datar, and Timothy J Scannell.
View insider buying and selling activity for Stryker
or view top insider-selling stocks.

Which institutional investors are buying Stryker stock?

SYK stock was bought by a variety of institutional investors in the last quarter, including Baystate Wealth Management LLC, Bath Savings Trust Co, Loring Wolcott & Coolidge Fiduciary Advisors LLP MA, Bainco International Investors, Tandem Investment Advisors Inc., IFM Investors Pty Ltd, Louisiana State Employees Retirement System, and Capital Investment Services of America Inc..
View insider buying and selling activity for Stryker
or or view top insider-buying stocks.

How do I buy shares of Stryker?

Shares of SYK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Stryker's stock price today?

One share of SYK stock can currently be purchased for approximately $241.99.

How big of a company is Stryker?

Stryker has a market capitalization of $90.94 billion and generates $14.88 billion in revenue each year. The medical technology company earns $2.08 billion in net income (profit) each year or $8.26 on an earnings per share basis. Stryker employs 40,000 workers across the globe.

What is Stryker's official website?

The official website for Stryker is www.strykercorp.com.

How can I contact Stryker?

Stryker's mailing address is 2825 AIRVIEW BLVD, KALAMAZOO MI, 49002. The medical technology company can be reached via phone at 269-389-2600 or via email at [email protected]

This page was last updated on 1/16/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.